Eliot C. Williams, MD, PhD Print Friendly Page
Faculty, University of Wisconsin School of Medicine and Public HealthEliot Williams, MD, PhD, is a long-standing member of the faculty of the Section of Hematology at the University of Wisconsin-Madison School of Medicine and Public Health. In conjunction with the other hematology physicians, Dr. Williams provides inpatient and outpatient care for hematology patients. He is currently serving as Section Head of Hematology. His clinical interests include: the treatment of bleeding and clotting disorders and leukemia.
Specialties
UW Health Clinics
UW Hospital and Clinics
(866) 737-6707
| (800) 323-8942
| Map
Hospital Affiliation(s)
University of Wisconsin Hospital and Clinics (primary)
Languages Spoken
| English |
| Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000. |
UW School of Medicine and Public Health
| Department of Medicine |
Professional Certifications and Education
| Board Certification |
Internal Medicine
Hematology |
| Fellowship |
University of Wisconsin Hospital and Clinics, Madison, WI
|
| Residency |
University of Wisconsin Hospital and Clinics, Madison, WI
|
| Internship |
University of Wisconsin Hospital and Clinics, Madison, WI
|
| Medical School |
Indiana University, Indianapolis, 1976
|
Awards/Honors
Procedures
Our doctors provide a wide range of services. The following list represents some, but not all, of the procedures offered by this physician.
Programs & Conditions
| Research |
Dr. Williams' research interests include bleeding and clotting disorders and leukemia. |
PubMed Articles
-
Micic D Williams EC Medow JE .
Cerebellar hemorrhage as a first presentation of acquired Hemophilia A. Neurocrit Care. 2011 Aug;15(1):170-4
[PubMed ID: 21713596]
-
O'Connor SD Taylor AJ Williams EC Winter TC .
Coagulation concepts update. AJR Am J Roentgenol. 2009 Dec;193(6):1656-64
[PubMed ID: 19933661]
-
Chang JE Medlin SC Kahl BS Longo WL Williams EC Lionberger J Kim K Kim J Esterberg E Juckett MB .
Augmented and standard Berlin-Frankfurt-Munster chemotherapy for treatment of adult acute lymphoblastic leukemia. Leuk Lymphoma. 2008 Dec;49(12):2298-307
[PubMed ID: 19052977]
-
Young KH Zhang D Malik JT Williams EC .
Fulminant EBV-driven CD8 T-cell lymphoproliferative disorder following primary acute EBV infection: a unique spectrum of T-cell malignancy. Int J Clin Exp Pathol. 2008 Jan 1;1(2):185-97
[PubMed ID: 18784807]
-
Kujawski LA Longo WL Williams EC Turman NJ Brandt N Mosher DF Eickhoff JC Kahl BS .
A 5-drug regimen maximizing the dose of cyclophosphamide is effective therapy for adult Burkitt or Burkitt-like lymphomas. Cancer Invest. 2007 Mar;25(2):87-93
[PubMed ID: 17453819]
-
Kahl BS Bailey HH Smith EP Turman N Smith J Werndli J Williams EC Longo WL Kim KM McGovern J Jumonville A .
Phase II study of weekly low-dose paclitaxel for relapsed and refractory non-Hodgkin's lymphoma: a Wisconsin Oncology Network Study. Cancer Invest. 2005;23(1):13-8
[PubMed ID: 15779863]
-
Kobbervig C Williams E .
FXIII polymorphisms, fibrin clot structure and thrombotic risk. Biophys Chem. 2004 Dec 20;112(2-3):223-8
[PubMed ID: 15572253]
-
Warner TF Wrone DA Williams EC Cripps DJ Mundhenke C Friedl A .
Heparan sulphate proteoglycan in scleromyxedema promotes FGF-2 activity. Pathol Res Pract. 2002;198(10):701-7
[PubMed ID: 12498227]
